TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -97.4% | 270 | -98.0% | 0.00% | – |
| Q1 2022 | $38,000 | -40.6% | 13,763 | 0.0% | 0.00% | – |
| Q4 2021 | $64,000 | -46.2% | 13,763 | -1.6% | 0.00% | – |
| Q3 2021 | $119,000 | -73.8% | 13,980 | -49.6% | 0.00% | – |
| Q2 2021 | $455,000 | -10.4% | 27,727 | +20.6% | 0.00% | -100.0% |
| Q1 2021 | $508,000 | -28.6% | 22,993 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $711,000 | +133.1% | 22,993 | +53.4% | 0.00% | – |
| Q3 2020 | $305,000 | +32.6% | 14,993 | 0.0% | 0.00% | – |
| Q2 2020 | $230,000 | +132.3% | 14,993 | +17.1% | 0.00% | – |
| Q1 2020 | $99,000 | -45.9% | 12,800 | 0.0% | 0.00% | – |
| Q4 2019 | $183,000 | +90.6% | 12,800 | +100.0% | 0.00% | – |
| Q3 2019 | $96,000 | -4.0% | 6,400 | -8.6% | 0.00% | – |
| Q2 2019 | $100,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |